4.5 Article

Synthesis, characterization, and biological evaluation of some novel Schiff bases as potential metabolic enzyme inhibitors

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyond

Maju Mathew Koola

Summary: Development of novel treatments for positive, cognitive, and negative symptoms in schizophrenia remains a high priority, with a need for combination treatments targeting different mechanisms of action. Previous studies targeting specific systems or receptors have not been successful, highlighting the importance of exploring new approaches to address the multiple domains of psychopathology in schizophrenia.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2021)

Article Pharmacology & Pharmacy

Post-market utilization patterns of Alzheimer's disease treatments in South Korea: comparison with countries with universal health coverage

Hye-Jae Lee et al.

Summary: This study compared the utilization of Alzheimer's disease treatments in Korea with Australia and other countries with universal health coverage. The findings showed significant differences in cost and utilization trends between Korea and Australia, despite both having similar UHC systems. Additionally, Korea's cost of AD treatments remained higher compared to Norway and England, with a different cost trend.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Review Chemistry, Medicinal

Acetylcholinesterase inhibitors for the treatment of Alzheimer's disease - a patent review (2016-present)

Martina Bortolami et al.

Summary: Alzheimer's Disease (AD) has a multifactorial etiology and current therapies are unable to interrupt its progression. Research is focused on developing new multi-target therapies, which may hold great therapeutic potential in addressing the urgent need for effective treatments.

EXPERT OPINION ON THERAPEUTIC PATENTS (2021)

Article Chemistry, Physical

Iron (III) and zinc (II) monodentate Schiff base metal complexes: Synthesis, characterisation and biological activities

Bushra Naureen et al.

Summary: Schiff bases, known for their diverse pharmacological activities, were complexed with metal ions to form metal complexes, which showed enhanced antibacterial and antifungal activities. Metal complexes have the potential to be explored as active pharmaceutical agents.

JOURNAL OF MOLECULAR STRUCTURE (2021)

Review Chemistry, Medicinal

A review: Pharmacological aspects of metal based 1,2,4-triazole derived Schiff bases

Wardha Zafar et al.

Summary: Clinical reports have emphasized the increasing threat of multidrug resistance due to antibiotic resistance. Research has shown that organic compounds now require metal ions for bio-transformation in order to enhance their potentiality against resistance. Metal based drugs have played an imperative role in developing new strategies with significant biological activity, safety, and efficacy. In recent years, metal based compounds have been of great interest for treating various diseases, filling the gap left by conventional methodologies.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Physical

Synthesis, characterization, biological evaluation, BSA binding properties, density functional theory and molecular docking study of Schiff bases

Nenad Joksimovic et al.

Summary: By synthesizing and testing Schiff base compounds, their potential in antioxidant and antimicrobial activities has been confirmed. B1 compound showed the highest activity in all experiments, with B2 and C3 compounds also demonstrating strong antioxidant effects. In terms of antimicrobial activity, B1 and B2 showed significant antibacterial effects, while C4 and B1 exhibited strong antifungal effects.

JOURNAL OF MOLECULAR STRUCTURE (2021)

Article Chemistry, Multidisciplinary

Heterocyclic Schiff base derivatives containing pyrazolone moiety: Synthesis, characterization, and in vitro biological studies

Ercan Cinar et al.

Summary: Novel pyrazolone-based Schiff base derivatives were synthesized and evaluated for their anticancer, antioxidant, and enzyme inhibitory activities, showing potential pharmacological applications with significant antiproliferative effects against HeLa cells, as well as strong antioxidant and enzyme inhibitory properties.

JOURNAL OF THE CHINESE CHEMICAL SOCIETY (2021)

Article Chemistry, Physical

Synthesis, density functional theory study, molecular dynamics simulation and anti-corrosion performance of two benzidine Schiff bases

Abdelghani Madani et al.

Summary: Two Schiff bases, BT and BD, were synthesized and characterized in this study. Their corrosion inhibition performance on mild steel in hydrochloric acid medium was investigated using weight loss method and electrochemical techniques. Experimental and simulation results showed that these compounds exhibited good inhibition action at low concentrations and their efficiency increased with concentration.

JOURNAL OF MOLECULAR STRUCTURE (2021)

Article Chemistry, Physical

Antiproliferative properties and structural analysis of newly synthesized Schiff bases bearing pyrazole derivatives and molecular docking studies

Nesrin Sener et al.

Summary: New pyrazole Schiffbases containing azo groups were synthesized and characterized by various spectroscopic techniques. Compound 4 showed significant antimicrobial activity against Salmonella typhimurium, high protection activity on DNA, and cytotoxic activity on HeLa cancer cells. The anti-cancer properties of compounds 4 and 5 were also analyzed through molecular docking study, with compound 4 exhibiting promising results in vitro.

JOURNAL OF MOLECULAR STRUCTURE (2021)

Article Biochemistry & Molecular Biology

Heterocyclic Schiff Bases of 3-Aminobenzanthrone and Their Reduced Analogues: Synthesis, Properties and Spectroscopy

Natalja Orlova et al.

Summary: New substituted azomethines of benzanthrone with heterocyclic substituents were synthesized and characterized by various spectroscopic methods. The luminescence of the resulting amines was more pronounced compared to the initial azomethines, with a strong sensitivity to solvent polarity. The obtained compounds show promise as luminescent dyes in organic synthesis.

MOLECULES (2021)

Review Chemistry, Multidisciplinary

Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer's Disease

Laura Del Amo et al.

Summary: Conventional medications for AD fail to slow down the progression of the disease, calling for new therapeutic approaches. Nanoparticles are considered effective drug delivery systems to overcome the BBB, with PLGA-NPs being particularly promising. This treatment strategy holds potential for site-specific drug delivery.

APPLIED SCIENCES-BASEL (2021)

Review Biochemistry & Molecular Biology

Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease

Teeba Athar et al.

Summary: Alzheimer's disease is a complex, multifactorial, and progressive neurodegenerative disease with currently limited treatment options. Despite global efforts to identify new therapeutic agents, only one drug has been approved by the FDA for the treatment of AD since 2003. Further research is needed to develop novel therapeutic strategies to combat this century-old disease.

MOLECULAR BIOLOGY REPORTS (2021)

Proceedings Paper Materials Science, Multidisciplinary

Aminopyridine derived azomethines as potent antimicrobial agents

F. M. Mashood Ahamed et al.

Summary: This study explores the wide therapeutic applications of imines by synthesizing them and conducting structural analysis and in vitro antimicrobial activity screening of the compounds. The results show that all compounds exhibit excellent antimicrobial activity against bacterial and fungi pathogens.

MATERIALS TODAY-PROCEEDINGS (2021)

Article Clinical Neurology

Evaluation of rivastigmine in Alzheimer's disease

Kevin Nguyen et al.

Summary: Dementia, particularly Alzheimer's disease, is a leading cause of death and disability among older adults. Cholinesterase inhibitors, with rivastigmine being the only one to inhibit specific brain enzymes, are the main drugs used for management. The availability of rivastigmine as a skin patch improves administration and patient adherence, with evidence from clinical trials supporting its positive impact on cognitive abilities with good safety profiles.

NEURODEGENERATIVE DISEASE MANAGEMENT (2021)

Article Biochemistry & Molecular Biology

Benzimidazole derivatives as potent and isoform selective tumor-associated carbonic anhydrase IX/XII inhibitors

Azize Gizem Uslu et al.

BIOORGANIC CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Design, synthesis and molecular modelling studies of some pyrazole derivatives as carbonic anhydrase inhibitors

Yazgi Dizdaroglu et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)

Review Chemistry, Medicinal

New approaches for the treatment of Alzheimer's disease

Paul V. Fish et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Article Biochemistry & Molecular Biology

Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies

Huseyin Cavdar et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)

Review Biochemistry & Molecular Biology

Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review

Khalid Karrouchi et al.

MOLECULES (2018)

Article Biochemistry & Molecular Biology

Effects of aryl methanesulfonate derivatives on acetylcholinesterase and butyrylcholinesterase

Kani Zilbeyaz et al.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2018)

Review Chemistry, Medicinal

Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines

Dorota Olender et al.

PHARMACEUTICALS (2018)

Article Engineering, Electrical & Electronic

Diester Molecules for Organic-Based Electrical and Photoelectrical Devices

Giray Topal et al.

JOURNAL OF ELECTRONIC MATERIALS (2017)

Article Chemistry, Medicinal

Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors

Raed Yaseen et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Review Clinical Neurology

Drug development in Alzheimer's disease: the path to 2025

Jeffrey Cummings et al.

ALZHEIMERS RESEARCH & THERAPY (2016)

Article Chemistry, Medicinal

Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives

Semra Isik et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Article Chemistry, Medicinal

Synthesis and carbonic anhydrase inhibitory properties of novel uracil derivatives

Murat Guney et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Article Geriatrics & Gerontology

The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease

William James Deardorff et al.

DRUGS & AGING (2015)

Article Spectroscopy

Synthesis of novel Schiff's bases of highly potential biological activities and their structure investigation

Ehab M. Zayed et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2015)

Article Biochemistry & Molecular Biology

Synthesis, Characterization and Anti-Breast Cancer Activity of New 4-Aminoantipyrine-Based Heterocycles

Mostafa M. Ghorab et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Article Food Science & Technology

Antibacterial and Cytotoxic Activities of Schiff Base Analogues of 4-Aminoantipyrine

Mohammad Sayed Alam et al.

JOURNAL OF THE KOREAN SOCIETY FOR APPLIED BIOLOGICAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Purification and characterization of carbonic anhydrase from sheep kidney and effects of sulfonamides on enzyme activity

Ramazan Demirdag et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2013)

Review Biotechnology & Applied Microbiology

Carbonic anhydrase: Its biocatalytic mechanisms and functional properties for efficient CO2 capture process development

Bashistha Kumar Kanth et al.

ENGINEERING IN LIFE SCIENCES (2013)

Article Chemistry, Medicinal

Synthesis and carbonic anhydrase inhibitory properties of novel cyclohexanonyl bromophenol derivatives

Halis T. Balaydin et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Biochemistry & Molecular Biology

Simple methanesulfonates are hydrolyzed by the sulfatase carbonic anhydrase activity

Elif Akin Kazancioglu et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)

Article Chemistry, Medicinal

Synthesis and enzyme inhibitory activities of some new pyrazole-based heterocyclic compounds

Tariq Harit et al.

MEDICINAL CHEMISTRY RESEARCH (2012)

Article Chemistry, Medicinal

Carbonic anhydrase inhibitors

Claudiu T. Supuran

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Review Neurosciences

Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?

Alessandro Martorana et al.

CNS NEUROSCIENCE & THERAPEUTICS (2010)

Article Chemistry, Medicinal

Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety

Mostafa M. Ghorab et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)

Article Clinical Neurology

Alzheimer's disease

Roy Yaari et al.

SEMINARS IN NEUROLOGY (2007)

Review Pharmacology & Pharmacy

Cholinesterase inhibitors for Alzheimer's disease

J Grutzendler et al.

DRUGS (2001)

Letter Chemistry, Medicinal

Carbonic anhydrase inhibitors - Part 94. 1,3,4-thiadiazole-2-sulfonamide derivatives as antitumor agents?

CT Supuran et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2000)